Insider Shareholders with Direct Ownership of Artiva Biotherapeutics, Inc. (RTVA)
This section provides a comprehensive overview of the insiders with direct ownership of Artiva Biotherapeutics, Inc. (RTVA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Artiva Biotherapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
1,936,637 | 0 | 1,936,637 | 1 |
Jul 22, 2024
Added 17.71%
|
|
Fred Aslan
President and CEO |
228,905 | 0 | 228,905 | 1 |
Jul 22, 2024
Added 50.0%
|
194,108 | 0 | 194,108 | 1 |
Jul 22, 2024
Added 20.16%
|
|
Jennifer Bush
COO, CLO, Secy, Compliance Off |
50,000 | 0 | 72,799 | 1 |
Sep 12, 2024
Added 40.72%
|
Neha Krishnamohan
Chief Financial Officer |
50,000 | 0 | 50,000 | 1 |
Sep 12, 2024
Added 50.0%
|
Christopher Horan
Chief Tech Operations Officer |
25,000 | 0 | 25,000 | 1 |
Sep 12, 2024
Added 50.0%
|
Thorsten Graef
Chief Medical Officer |
20,000 | 0 | 20,000 | 1 |
Sep 12, 2024
Added 50.0%
|
Heather Raymon
SVP, Research and Development |
10,000 | 0 | 10,000 | 1 |
Sep 12, 2024
Added 50.0%
|
2,958,063 | 0 | 0 | 1 |
N/A
|